Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(20%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
2
20%
Ph phase_2
1
10%
Ph phase_1
2
20%
Ph phase_4
5
50%

Phase Distribution

2

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 21 (10.0%)
Phase 32 (20.0%)
Phase 45 (50.0%)

Trials by Status

unknown220%
recruiting220%
completed550%
not_yet_recruiting110%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_4

Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

NCT07511257
not_yet_recruitingphase_4

Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease

NCT07080684
recruitingphase_4

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

NCT06821191
unknownphase_1

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

NCT06164834
completedphase_3

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

NCT04738097
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07511257Phase 4

Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

Recruiting
NCT07080684Phase 4

Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease

Not Yet Recruiting
NCT06821191Phase 4

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Recruiting
NCT06164834Phase 1

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

Unknown
NCT04738097Phase 3

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Completed
NCT05210595Phase 4

Optimal Dosage of Ticagrelor in Korean Patients With AMI

Unknown
NCT02944123Phase 3

Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

Completed
NCT03814642Phase 1

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

Completed
NCT02567461Phase 4

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Completed
NCT01097343Phase 2

Clopidogrel Pharmacogenomics Project

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10